ISRCTN89345269已完成4 期
A randomised controlled trial of warfarin vs aspirin for atrial fibrillation in an elderly (aged 75 and over) primary care population: Birmingham Atrial Fibrillation Treatment of the Aged study
niversity of Birmingham (UK)0 个研究点目标入组 973 人开始时间: 2000年10月23日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 973
研究概览
简要总结
2003 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/12939169 2007 main results in: http://www.ncbi.nlm.nih.gov/pubmed/17693178 2007 secondary analysis in: http://www.ncbi.nlm.nih.gov/pubmed/16887213 2010 recruitment analysis in: http://www.ncbi.nlm.nih.gov/pubmed/20610490 2014 results in: http://www.ncbi.nlm.nih.gov/pubmed/24692475
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age 75 or over
- •2. Non-rheumatic atrial fibrillation confirmed by electrocardiogram (ECG)
排除标准
- •1. Already on warfarin
- •2. History of major haemorrhage
- •3. Recent peptic ulcer disease (previous year)
- •4. Sensitivity to any of the study medications
- •5. Rheumatic heart disease
研究者
相似试验
撤回
4 期
Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney DiseaseAtrial FibrillationChronic Kidney DiseaseNCT01668901Seoul National University Hospital
已完成
不适用
Prevention of Venous Thrombosis After Permanent Transvenous Leads ImplantationCardiac PacingComplicationsVenous ThrombosisNCT00621491University of Sao Paulo101
撤回
1 期
Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial DissectionIschemic StrokeNCT00265408University of California, San Diego
已完成
不适用
Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism StudyAnticoagulants and Bleeding DisordersVenous ThromboembolismNCT03292666University of California, San Francisco39,603
已完成
3 期
Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial FibrillationBleedingStrokeAtrial FibrillationNCT03702582Massachusetts General Hospital100